VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ORGO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ORGOOrganogenesis Holdings Inc.
$1.28$166M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksORGOQuarterly Financials

Organogenesis Holdings Inc. (ORGO) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Organogenesis Holdings Inc. (ORGO) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ORGO Income Statement

Quarterly statement

ORGO Income Statement

Organogenesis Holdings Inc. (ORGO) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue43.76M37.23M225.07M150.49M100.78M86.69M126.66M115.18M130.23M109.98M99.65M108.53M117.32M107.64M115.52M116.86M121.4M97.12M128.56M113.75M
Revenue Growth %-56.58%-57.06%77.7%30.66%-22.62%-21.17%27.1%6.12%11.01%2.17%-13.73%-7.13%-3.36%10.84%-10.14%2.73%-1.46%-5.3%20.36%12.85%
Cost of Goods Sold23.67M38.14M49.92M36.25M27.63M23.72M31.05M26.8M29.2M28.7M27.77M25.79M26.32M26.61M27.11M26.18M26.65M25.08M32.6M26.17M
COGS % of Revenue54.1%102.46%22.18%24.09%27.42%27.36%24.52%23.27%22.42%26.09%27.87%23.76%22.43%24.72%23.47%22.4%21.95%25.82%25.36%23%
Gross Profit20.08M-914K175.15M114.24M73.15M62.97M95.61M88.38M101.04M81.28M71.88M82.74M91M81.03M88.41M90.68M94.75M72.04M95.96M87.59M
Gross Margin %45.9%-2.46%77.82%75.91%72.58%72.64%75.48%76.73%77.58%73.91%72.13%76.24%77.57%75.28%76.53%77.6%78.05%74.18%74.64%77%
Gross Profit Growth %-72.55%-101.45%83.2%29.25%-27.6%-22.53%33%6.82%11.03%0.3%-18.69%-8.76%-3.96%12.49%-7.87%3.53%1.6%-6.51%18.05%12.53%
Operating Expenses71.07M64.12M109.92M92.59M83.98M83.15M85.39M82.14M114.93M85.13M73.15M74.69M81.25M85.04M79.69M88.9M82.81M72.17M75.51M71.32M
OpEx % of Revenue162.44%172.23%48.84%61.52%83.33%95.91%67.42%71.32%88.25%77.41%73.41%68.82%69.26%79%68.98%76.08%68.22%74.31%58.74%62.7%
Selling, General & Admin53.97M65.19M100.17M79.74M73.81M72.51M73.86M71.8M76.54M72.32M61.38M64.22M70.32M73.83M68.29M79.33M72.61M63.58M67.25M62.37M
SG&A % of Revenue123.33%175.1%44.51%52.99%73.24%83.64%58.31%62.33%58.77%65.76%61.6%59.17%59.94%68.59%59.12%67.88%59.81%65.47%52.31%54.83%
Research & Development18.3M15.16M10.29M13.22M10.39M10.64M11.53M10.34M15.59M12.81M11.77M10.47M10.94M11.2M11.39M9.57M10.21M8.59M8.26M8.95M
R&D % of Revenue41.82%40.72%4.57%8.79%10.31%12.27%9.1%8.98%11.97%11.65%11.81%9.65%9.32%10.41%9.86%8.19%8.41%8.84%6.43%7.87%
Other Operating Expenses-1000K-1000K-536K-377K-226K0001000K00000000000
Operating Income-50.99M-65.03M65.23M21.65M-10.83M-20.18M10.22M6.24M-13.89M-3.85M-1.27M8.05M9.74M-4M8.72M1.78M11.94M-128K20.45M16.26M
Operating Margin %-116.54%-174.69%28.98%14.39%-10.75%-23.28%8.07%5.42%-10.67%-3.5%-1.27%7.42%8.31%-3.72%7.55%1.52%9.83%-0.13%15.91%14.3%
Operating Income Growth %-370.84%-222.28%538.31%246.83%22.04%-423.86%905.28%-22.46%-242.56%3.72%-114.56%352.5%-18.35%-3025.78%-57.37%-89.06%-49.4%-101.01%-6.06%-28.67%
EBITDA-47.32M-52.66M72.24M28.64M-4.17M-13.9M14.67M10.65M-9.69M121K11.03M13.89M13.2M-77K13.27M4.46M14.68M2.44M25.27M21M
EBITDA Margin %-108.16%-141.46%32.1%19.03%-4.14%-16.03%11.58%9.24%-7.44%0.11%11.06%12.8%11.25%-0.07%11.49%3.81%12.1%2.51%19.66%18.46%
EBITDA Growth %-1033.51%-278.98%392.51%168.98%56.92%-11584.3%33.04%-23.38%-173.41%257.14%-16.94%211.9%-10.09%-103.16%-47.48%-78.78%-46.26%-84.75%5.43%-16.61%
D&A (Non-Cash Add-back)3.67M12.37M7.01M6.99M6.66M6.28M4.45M4.4M4.2M3.97M12.29M5.84M3.46M3.92M4.55M2.68M2.75M2.57M4.82M4.73M
EBIT-50.88M-68.47M63.43M21.16M-11.83M-25.78M10.19M6.29M-13.92M-3.83M-1.29M8.08M9.77M-3.98M8.72M1.78M11.91M-131K20.44M14.36M
Net Interest Income0380K236K415K669K961K61K-471K-620K-514K-502K-444K-594K-649K30K-572K-730K-737K-853K-1.48M
Interest Income0380K236K415K669K961K0000000030K00000
Interest Expense000000-61K471K620K514K502K444K594K649K0572K730K737K853K1.48M
Other Income/Expense112K-3.44M-1.8M-489K-1M-5.6M34K-419K-648K-491K-527K-413K-566K-626K36K-567K-751K-740K-862K-3.38M
Pretax Income-50.88M-68.47M63.43M21.16M-11.83M-25.78M10.25M5.82M-14.54M-4.34M-1.8M7.64M9.18M-4.63M8.75M1.21M11.18M-868K19.59M12.88M
Pretax Margin %-116.28%-183.93%28.18%14.06%-11.74%-29.74%8.1%5.06%-11.16%-3.95%-1.8%7.04%7.82%-4.3%7.58%1.04%9.21%-0.89%15.24%11.32%
Income Tax45.39M-12.31M19.73M-407K-2.44M-6.94M2.58M-6.51M2.5M-2.24M-1.23M4.47M3.86M-1.66M1.27M997K2.44M45K-32.11M303K
Effective Tax Rate %-89.2%17.98%31.1%-1.92%20.64%26.92%25.16%-111.76%-17.21%51.65%68.37%58.53%42.09%35.83%14.48%82.26%21.82%-5.18%-163.9%2.35%
Net Income-99.34M-56.16M43.7M21.57M-9.39M-18.84M7.67M12.33M-17.04M-2.1M-568K3.17M5.32M-2.97M7.49M215K8.74M-913K51.7M12.58M
Net Margin %-227.03%-150.85%19.42%14.33%-9.32%-21.74%6.06%10.71%-13.09%-1.91%-0.57%2.92%4.53%-2.76%6.48%0.18%7.2%-0.94%40.21%11.06%
Net Income Growth %-957.7%-198.04%469.53%74.9%44.89%-797.29%1450.88%289.36%-420.6%29.27%-107.59%1373.02%-39.2%-225.19%-85.52%-98.29%-57.73%-109.18%179.52%-39.4%
Net Income (Continuing)-96.27M-56.16M43.7M21.57M-9.39M-18.84M7.67M12.33M-17.04M-2.1M-568K3.17M5.32M-2.97M7.49M215K8.74M-913K51.7M12.58M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.77-0.440.270.11-0.10-0.170.040.09-0.13-0.02-0.000.020.04-0.020.060.000.070.000.390.09
EPS Growth %-700.42%-158.82%516.44%19.44%26%-969.18%-288.61%-425%29.65%-107.57%--39.3%--85.44%-98.22%-56.07%-99%160%-52.63%
EPS (Basic)-0.77-0.440.280.11-0.10-0.170.050.09-0.13-0.02-0.000.020.04-0.020.060.000.070.000.400.10
Diluted Shares Outstanding128.67M127.8M132.21M130.85M126.85M126.3M132.16M133.93M132.57M131.86M131.86M133.42M133.07M131.08M131.86M132.23M132.6M132.81M133.35M133.85M
Basic Shares Outstanding128.67M127.8M126.91M126.88M126.85M126.3M131.67M132.58M132.57M131.86M130.92M131.31M131.29M131.08M130.92M130.9M129.64M128.79M128.66M128.55M
Dividend Payout Ratio--------------------